2024 Guideline for the Management of Hypertrophic Cardiomyopathy
1:06:46
FSR Webinar on Advanced Pulmonary and Cardiac Sarcoidosis
14:54
2024 Guideline for the Management of Lower Extremity Peripheral Artery Disease
10:31
AHA 24: VALOR-HCM: Mavacamten in Patients with Obstructive HCM Referred for Septal Reduction Therapy
31:31
Hypertrophic Cardiomyopathy Update (BIDMC)
14:39
Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024
7:20
AHA 24: Mavacamten: Real-World Experience from 22 Months of the REMS Program
13:57
2024 Guideline for the Primary Prevention of Stroke
16:29